Reduced protein loss during hemofiltration using Cuprophan membranes

Area of Science:

• Nephrology
• Biomedical Engineering
• Renal Replacement Therapy

Background:

• Hemofiltration is a renal replacement therapy used to remove fluid and solutes from the blood.
• Cuprophan membranes are commonly used in dialysis and hemofiltration procedures.
• Understanding protein loss during hemofiltration is crucial for patient management and therapy optimization.

Purpose of the Study:

• To quantify protein loss during hemofiltration using Cuprophan membranes.
• To investigate the relationship between transmembrane pressure (TMP) and protein loss.
• To assess the impact of hemofiltration on serum protein levels.

Main Methods:

• Four patients underwent one hour of hemofiltration followed by three hours of hemodialysis.
• Protein loss was measured at varying transmembrane pressures (300 mmHg and 600 mmHg).
• Serum protein levels were monitored throughout the hemofiltration period.

Main Results:

• Protein loss during hemofiltration was minimal, ranging from 0.013 mg/mg to 0.012 mg/ml.
• Protein loss was independent of transmembrane pressure (TMP).
• Serum protein levels remained unchanged, with no evidence of protein wastage.

Conclusions:

• Hemofiltration with Cuprophan membranes results in negligible protein loss.
• Transmembrane pressure does not significantly influence protein loss during hemofiltration.
• This study suggests hemofiltration is a safe procedure regarding protein balance in patients.